NMR (400 MHz, CDCl3) d 1.42 (9H, s, (C(CH3)3), 1.56–1.66 (2H,
m, Ha3 and Ha6), 1.74–1.79 (1H, m, Hb6), 2.30–2.37 (1H, m, Hb3),
2.54 (1H, dd, J 9.8 4.4 Hz, Ha5), 2.61–2.64 (1H, m, H2), 3.10–3.18
(4H, m, Hb5, Ha7, Ha8 and Hb8), 3.56 (1H, d, J 16.8 Hz, Hb7),
3.70 (3H, s, OCH3), 4.25 (1H, br s, H4); 13C NMR (100.6 MHz,
CDCl3) d 28.3 (C(CH3)3), 32.8 (C6), 37.3 (C8), 40.2 (C3), 51.6
(OCH3), 53.4 (C7), 60.5 (C2), 62.6 (C5), 69.6 (C4), 78.9 (C(CH3)3),
5.2 Hz, Hb5), 3.55 (1H, d, J 17.6 Hz, Hb7), 3.69 (3H, s, OCH3),
4.26–4.28 (1H, m, H4); 13C NMR (100.6 MHz, CDCl3) d 28.2
(C(CH3)3), 32.7 (C6), 37.3 (C8), 40.5 (C3), 51.6 (OCH3), 53.2 (C7),
t
59.1 (C2), 61.8 (C5), 69.9 (C4), 78.8 (C(CH3)3), 155.9 (CO2 Bu),
172.2 (CO2CH3); m/z (ES) 303 ([M + H]+ 100%); HRMS m/z
(ES) 303.1914, calculated for C14H27O5N2 303.1914.
156.0 (CO2 Bu), 171.4 (CO2CH3); m/z (ES) 325 ([M + Na]+ 100%),
t
(2ꢀS,4ꢀR)-2-[2-(tert-Butoxycarbonylamino)ethyl]-4-(N3-
benzoylthymin-1-yl)-N-(methoxycarbonylmethyl)pyrrolidine (17)
303 ([M + H]+ 85%); HRMS m/z (ES) 303.1913, calculated for
C14H27O5N2 303.1914.
To a solution of alcohol 17 (400 mg, 1.32 mmol) in anhydrous THF
(50 mL) under nitrogen, was added N3-benzoylthymine (370 mg,
1.61 mmol) and triphenylphosphine (420 mg, 1.60 mmol). The
(2S,4S)-2-[2-(tert-Butoxycarbonylamino)ethyl]-4-formyloxy-N-
(methoxycarbonylmethyl)pyrrolidine (15)
◦
mixture was cooled to −20 C and DIAD (360 lL, 1.83 mmol)
To a solution of alcohol 14 (3.20 g, 10.59 mmol) in anhydrous THF
(50 mL) under nitrogen, was added triphenylphosphine (3.60 g,
13.73 mmol). The solution was cooled to −20 ◦C and anhydrous
formic acid (560 lL, 13.78 mmol) was added followed by dropwise
addition of DIAD (2.75 mL, 13.97 mmol). The reaction mixture
was allowed to warm to room temperature and stirred under
nitrogen for 18 h. Triphenylphosphine (1.80 g, 6.87 mmol) was
added and the reaction mixture was cooled to −20 ◦C, anhydrous
formic acid (260 lL, 6.89 mmol) was added followed by dropwise
addition of DIAD (1.38 mL, 6.99 mmol). The reaction mixture was
allowed to warm to room temperature and stirred under nitrogen
for 3 h. Solvent was removed under reduced pressure and flash
chromatography (1 : 1 hexanes–EtOAc Rf 0.3) afforded formyl
ester 15 (2.45 g, 70%) as a pale yellow oil. [a]D−10.2◦ (c = 1,
was added dropwise. The reaction mixture was allowed to warm to
room temperature and stirred under nitrogen for 18 h. Solvent was
removed under reduced pressure and flash chromatography (1 : 1
hexanes–EtOAc Rf 0.4) afforded thyminyl derivative 17 (453 mg,
67%) as a white foam. Found: C 60.28; H 6.76, N 10.36, Calculated
for C26H34O7N4; C 60.69, H 6.66, N 10.89%; [a]D−49.3◦ (c =
0.5, CHCl3); mmax(KBr)/cm−1 3373 (NH), 1746, 1698, 1652 (CO);
1
kmax (CH3OH)/nm 252 (e/dm3mol−1 cm−1 1.6 × 104); H NMR
(400 MHz, CDCl3) d 1.42 (9H, s, C(CH3)3), 1.48–1.55 (1H, m,
Ha3ꢀ), 1.60 (1H, dd, J 13.9, 7.2 Hz, Ha6ꢀ), 1.83–1.91 (1H, m, Hb6ꢀ),
1.99 (3H, s, thymine CH3), 2.56–2.66 (3H, m, H2ꢀ, Hb3ꢀ and Ha5ꢀ),
2.99 (1H, d, J 17.2 Hz, Ha7ꢀ), 3.09–3.18 (2H, m, HaHb8ꢀ), 3.33
(1H, d, J 11.1 Hz, Hb5ꢀ), 3.69 (1H, d, J 17.2 Hz, Hb7ꢀ), 3.74
(3H, s, O–CH3), 4.85 (1H, br s, NH), 5.00–5.04 (1H, m, H4ꢀ), 7.47
(2H, t, J 7.5 Hz, Bz meta-H), 7.62 (1H, t, J 7.5 Hz, Bz para-H),
7.90 (2H, d, J 7.5 Hz, Bz ortho-H), 8.09 (1H, s, H6); 13C NMR
(100.6 MHz, CDCl3) d 12.7 (thymine CH3), 28.3 (C(CH3) 3), 32.6
(C6ꢀ), 37.2 (C8ꢀ), 38.7 (C3ꢀ), 51.8 (O-CH3), 51.9 (C4ꢀ), 52.7 (C7ꢀ),
58.7 (C5ꢀ), 60.7 (C2ꢀ), 79.3 (C(CH3)3), 111.3 (C5), 129.0 (Bz meta-
C), 130.3 (Bz ortho-C), 131.6 (Bz ipso-C), 134.8 (Bz para-C), 137.7
1
CHCl3); mmax(KBr)/cm−1 3336 (NH), 1739, 1720, 1685 (CO); H
NMR (400 MHz, CDCl3) d 1.43 (9H, s, (C(CH3)3), 1.50–1.59 (1H,
m, Ha6), 1.75–1.82 (1H, m, Hb6), 1.92 (1H, ddd, J 13.6, 6.7, 2.1 Hz,
Ha3), 2.04 (1H, ddd, J 13.6, 6.4, 2.2 Hz, Hb3), 2.54 (1H, dd, J 11.1,
3.6 Hz, Ha5), 2.92–2.98 (1H, m, H2), 3.09–3.19 (2H, m, Ha8 and
Hb8), 3.22 (1H, d, J 16.7 Hz, Ha7), 3.60 (1H, d, J 16.7 Hz, Hb7),
3.69 (1H, dd, J 11.1, 6.3 Hz, Hb5), 3.72 (3H, s, OCH3), 4.95 (1H,
br s, NH), 5.26–5.31 (1H, m, H4), 8.00 (1H, s, OCHO); 13C NMR
(100.6 MHz, CDCl3) d 28.4 (C(CH3)3), 32.4 (C6), 37.3 (C8), 37.4
(C3), 51.8 (OCH3), 54.0 (C7), 59.5 (C5), 59.9 (C2), 72.5 (C4), 79.1
t
(C6), 149.9 (C2), 155.8 (CO2 Bu), 162.8 (C4), 169.2 (Bz CO), 170.9
(CO2CH3); m/z (ES) 537 ([M + Na]+ 100%), 515 ([M + H]+ 60%);
HRMS m/z (ES) 515.2514, calculated for C26H35O7N4 515.2500.
t
(C(CH3)3), 155.9 (CO2 Bu), 160.5 (OCHO), 171.0 (CO2CH3); m/z
(2ꢀS,4ꢀR)-2-[2-(tert-Butoxycarbonylamino)ethyl]-4-(thymin-1-
yl)pyrrolidine-1-yl-acetic acid (18)
(ES) 331 ([M + H]+ 100%), 353 ([M + Na+] 40%); HRMS m/z
(ES) 331.1864, calculated for C15H27O6N2 331.1864.
To a solution of methyl ester 17 (400 mg, 0.78 mmol) in THF
(4 mL) was added 1 M aqueous NaOH (2.4 mL, 2.4 mmol)
and the reaction mixture was stirred at room temperature for
18 h. THF was removed under a stream of nitrogen and the
pH of the remaining aqueous solution was adjusted to 7 by
addition of 0.1 M aqueous HCl. Water was removed under reduced
pressure and the resulting white residue was submitted to column
chromatography (7 : 3 EtOAc–CH3OH Rf 0.2) followed by reversed
phase chromatography (BondElut C18, H2O–CH3CN 9 : 1), the
product was lyophilised to afford acid 18 (220 mg, 71%) as a white
powder. [a]D + 5.2◦ (c = 1, CH3OH); mmax(KBr)/cm−1 3353 br (OH),
1720, 1680, 1651 (CO); kmax (CH3OH)/nm 267 (e/dm3 mol-1 cm-1
1.27 × 104); 1HNMR(400MHz, CD3OD) d 1.35 (9H, s, (C(CH3)3),
1.72–1.77 (1H, m, Ha6ꢀ), 1.80 (3H, s, thymine CH3), 1.98–2.08 (2H,
m, Ha3ꢀ and Hb6ꢀ), 2.74–2.81 (1H, m, Hb3ꢀ), 3.03–3.08 (2H, m, Ha8ꢀ
and Hb8ꢀ), 3.28–3.38 (2H, m, H2ꢀ and Ha5ꢀ), 3.43 (1H, d, J 16.2 Hz,
Ha7), 3.74 (1H, d, J 16.2 Hz, Hb7ꢀ), 3.91 (1H, d, J 12.6 Hz, Hb5ꢀ),
(2S,4S)-2-[2-(tert-Butoxycarbonylamino)ethyl]-4-hydroxy-N-
(methoxycarbonylmethyl)pyrrolidine (16)
To a solution of formyl ester 15 (2.21 g, 6.68 mmol) in anhydrous
CH3OH (15 mL) under nitrogen, was added anhydrous sodium
methoxide (90 mg, 1.67 mmol). The reaction mixture was stirred
at room temperature for 2 h. Anhydrous sodium methoxide
(45 mg, 0.84 mmol) was added and the reaction mixture stirred
for a further 3 h. Solvent was removed under reduced pressure
and flash chromatography (EtOAc Rf 0.2) afforded 4S alcohol
16 (1.82 g, 90%) as a pale yellow oil. [a]D + 31.4◦ (c = 1,
CHCl3); mmax(KBr)/cm−1 3362 br (OH), 1744, 1690 (CO); 1H NMR
(400 MHz, CDCl3) d 1.39 (1H, s, (C(CH3)3), 1.44–1.51 (1H, m,
Ha6), 1.63–1.75 (2H, m, Ha3 and Hb6), 1.93 (1H, dd, J 13.0,
6.1 Hz, Hb3), 2.53 (1H, d, J 10.8 Hz, Ha5), 3.01–3.13 (3H, m, H2,
Ha8 and Hb8), 3.35 (1H, d, J 17.6 Hz, Ha7), 3.48 (1H, dd, J 10.8,
This journal is
The Royal Society of Chemistry 2008
Org. Biomol. Chem., 2008, 6, 92–103 | 99
©